New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
04:55 EDTPRGO, PRGO, QSII, QSII, PKI, PKI, AMAG, AMAG, AMBI, AMBI, LLY, LLY, WAT, WAT, CSII, CSII, BLUE, BLUELeerink to hold a conference
2014 Global Healthcare Conference is being held in New York on February 12-13.
News For PRGO;QSII;PKI;AMAG;AMBI;LLY;WAT;CSII;BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 4, 2015
09:07 EDTLLYFDA making testosterone product makers change labeling
Subscribe for More Information
March 3, 2015
08:04 EDTLLYDenovo Biopharma licensed Pomaglumetad Methionil from Eli Lilly
Subscribe for More Information
07:16 EDTLLYCowen to hold a conference
35th Annual Health Care Conference is being held in Boston on March 2-4 with webcasted company presentations to begin on March 3 at 8 am; not all company presentations may be webcasted. Webcast Link
06:14 EDTPRGOPerrigo investor sentiment could improve this year, says Deutsche Bank
Deutsche Bank believes Perrigo investor sentiment remains poor and says it "wouldn't wait for things to look perfect" to buy the stock. Deutsche thinks a return to consistent financial results, earnings growth acceleration in Q2 following the close of the Omega acquisition, and a possible investor day around May 5 could drive improved sentiment on the name. It lowered its price target for Perrigo shares to $200 from $204 and keeps a Buy rating on the stock.
March 2, 2015
08:53 EDTLLYNon-profit gives lukewarm review to MannKind inhaled insulin, TheStreet says
Subscribe for More Information
February 26, 2015
17:59 EDTAMAGAdage capital reports 10.7% passive stake in AMAG Pharmaceuticals
Subscribe for More Information
06:33 EDTBLUEbluebird bio price target raised to $119 from $112 at Piper Jaffray
Piper Jaffray raised its price target for bluebird bio to $119 following the company's Q4 results and reiterates an Overweight rating on the name. Piper sees 2015 as a "big year" for bluebird with preliminary sickle cell data.
February 25, 2015
18:32 EDTAMAGAMAG Pharmaceuticals 3.98M share Secondary priced at $44.00
Subscribe for More Information
16:03 EDTBLUEbluebird bio reports Q4 EPS (67c), consensus (57c)
Subscribe for More Information
February 24, 2015
18:15 EDTAMAGOn The Fly: After Hours Movers
Subscribe for More Information
16:06 EDTAMAGAMAG Pharmaceuticals files to sell $125M in common stock
Subscribe for More Information
06:34 EDTLLYEli Lilly CEO states company is not for sale, Financial Times says
Subscribe for More Information
February 23, 2015
08:31 EDTLLYEli Lilly announces delay in submission of basal insulin peglispro beyond Q1
Subscribe for More Information
07:22 EDTBLUESunTrust to hold a conference
2015 Biotechnology and Pharmaceutical 1:1 Orphan Drug Day is being held in New York on February 23.
07:07 EDTCSIICardiovascular Systems reports results from preclinical study on Diamondback 360
Cardiovascular Systems announced that CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education, and advancement of medical technologies, disclosed that modification of atherosclerotic plaque with CSI’s Diamondback 360 orbital atherectomy device improved paclitaxel absorption by 50% in calcified cadavaric peripheral arteries. Historically, plaque barriers in arteries have been reported to make drug diffusion and retention more difficult. Results from this ongoing preclinical study were presented by Elazer Edelman, M.D., Ph.D., Chairman and co-founder of CBSET, on Sunday, February 22, in a dedicated session on New Strategies for the Treatment of Calcified Lesions at the 2015 Cardiovascular Research Technologies conference in Washington, D.C. Said Dr. Edelman, “The results of our study demonstrated that benign lesion modification with CSI’s orbital atherectomy device improved paclitaxel delivery in human cadaver peripheral arteries with substantial calcified plaque burdens.”
07:06 EDTLLYEli Lilly and Incyte announces positive results for baricitinib
Subscribe for More Information
February 20, 2015
07:08 EDTPRGOAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.
February 19, 2015
08:04 EDTLLYEli Lilly extends Evacetrapib Phase 3 trial by six months
Subscribe for More Information
07:12 EDTBLUEWharton Health Care Club to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use